Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)
China · Delayed Price · Currency is CNY 10.36
-0.22 (-2.08%)
Mar 19, 2026, 1:25 PM CST
SHE:301060 Market Cap
SHE:301060 has a market cap or net worth of 4.22 billion as of March 18, 2026. Its market cap has decreased by -9.50% in one year.
Market Cap
4.22B
Enterprise Value
3.77B
Revenue
1.52B
Ranking
n/a
PE Ratio
n/a
Stock Price
10.36
Market Cap Chart
Since September 13, 2021, SHE:301060's market cap has decreased from 7.32B to 4.22B, a decrease of -42.38%. That is a compound annual growth rate of -11.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 4.22B | 14.38% |
| Dec 31, 2025 | 3.69B | 1.45% |
| Dec 31, 2024 | 3.63B | -31.73% |
| Dec 29, 2023 | 5.32B | -32.23% |
| Dec 30, 2022 | 7.85B | -43.54% |
| Dec 31, 2021 | 13.91B | 90.09% |
| Sep 13, 2021 | 7.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 8.43B |
| Beijing Strong Biotechnologies,Inc. | 7.37B |
| Maccura Biotechnology Co.Ltd | 6.93B |
| Cowealth Medical China | 6.51B |
| SMO ClinPlus CO.,LTD. | 4.90B |
| Thalys Medical Technology Group | 4.88B |
| Guangdong Hybribio Biotech | 4.16B |
| Berry Genomics Co.,Ltd | 4.02B |